• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

衡量耻辱感以评估与健康相关政策决策的社会正义影响:在耐多药结核病新型治疗方案中的应用

Measuring Stigma to Assess the Social Justice Implications of Health-Related Policy Decisions: Application to Novel Treatment Regimens for Multidrug-Resistant Tuberculosis.

作者信息

Dowdy David W, Zwerling Alice A, Stennett Andrea, Searle Alexandra, Dukhanin Vadim, Taylor Holly A, Merritt Maria W

机构信息

Departments of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

School of Epidemiology & Public Health, University of Ottawa, Ottawa, Canada.

出版信息

MDM Policy Pract. 2020 Apr 26;5(1):2381468320915239. doi: 10.1177/2381468320915239. eCollection 2020 Jan-Jun.

DOI:10.1177/2381468320915239
PMID:32440569
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7227142/
Abstract

In making policy decisions with constrained resources, an important consideration is the impact of alternative policy options on social justice. Social justice considers interactions between individuals and society and can be conceptualized across domains of agency, association, and respect. Despite its importance, social justice is rarely considered formally in health policy decision making, partially reflecting challenges in its measurement. We define three criteria for considering social justice in health-related policy decisions: 1) linkage of social justice to a measurable construct; 2) ability to reproducibly and feasibly estimate the impacts of a policy decision on the selected construct; and 3) appropriate presentation to decision makers of the expected social justice implications using that construct. We use preliminary data from qualitative interviews from three groups of respondents in South Africa and Uganda to demonstrate that stigma meets the first of these criteria. We then use the example of policy addressing novel treatment regimens for multidrug-resistant tuberculosis and a validated tuberculosis stigma scale to illustrate how policy effects on stigma could be estimated (criterion 2) and presented to decision makers in the form of justice-enhanced cost-effectiveness analysis (criterion 3). Finally, we provide a point-by-point guide for conducting similar assessments to facilitate consideration of social justice in health-related policy decisions. Our case study and guide for how to make social justice impacts more apparent to decision makers also illustrates the importance of local data and local capacity. Performing social justice assessments alongside more traditional evaluations of cost-effectiveness, budget impact, and burden of disease could help represent data-informed considerations of social justice in health care decision making more broadly.

摘要

在资源有限的情况下做出政策决策时,一个重要的考虑因素是替代政策选项对社会正义的影响。社会正义考虑个人与社会之间的互动,可以在能动性、关联性和尊重等领域进行概念化。尽管其很重要,但社会正义在卫生政策决策中很少被正式考虑,部分原因是其衡量存在挑战。我们定义了在与健康相关的政策决策中考虑社会正义的三个标准:1)将社会正义与可衡量的结构联系起来;2)能够以可重复和可行的方式估计政策决策对所选结构的影响;3)使用该结构向决策者适当地呈现预期的社会正义影响。我们使用来自南非和乌干达三组受访者的定性访谈的初步数据来证明耻辱感符合这些标准中的第一条。然后,我们以针对耐多药结核病新治疗方案的政策为例,并使用经过验证的结核病耻辱感量表来说明如何估计政策对耻辱感的影响(标准2),并以增强正义的成本效益分析的形式呈现给决策者(标准3)。最后,我们提供了一份逐点指南,用于进行类似评估,以促进在与健康相关的政策决策中考虑社会正义。我们的案例研究以及关于如何使社会正义影响对决策者更明显的指南也说明了本地数据和本地能力的重要性。在对成本效益、预算影响和疾病负担进行更传统评估的同时进行社会正义评估,有助于在更广泛的医疗保健决策中体现基于数据的社会正义考量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/344f/7227142/b65db6c7da2d/10.1177_2381468320915239-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/344f/7227142/b65db6c7da2d/10.1177_2381468320915239-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/344f/7227142/b65db6c7da2d/10.1177_2381468320915239-fig1.jpg

相似文献

1
Measuring Stigma to Assess the Social Justice Implications of Health-Related Policy Decisions: Application to Novel Treatment Regimens for Multidrug-Resistant Tuberculosis.衡量耻辱感以评估与健康相关政策决策的社会正义影响:在耐多药结核病新型治疗方案中的应用
MDM Policy Pract. 2020 Apr 26;5(1):2381468320915239. doi: 10.1177/2381468320915239. eCollection 2020 Jan-Jun.
2
Incorporating social justice and stigma in cost-effectiveness analysis: drug-resistant tuberculosis treatment.将社会公正和污名著入成本效益分析:耐多药结核病治疗。
Int J Tuberc Lung Dis. 2017 Nov 1;21(11):69-74. doi: 10.5588/ijtld.16.0839.
3
Ethical Considerations for Global Health Decision-Making: Justice-Enhanced Cost-Effectiveness Analysis of New Technologies for .全球卫生决策的伦理考量:新技术的正义增强型成本效益分析
Public Health Ethics. 2018 Jul 18;11(3):275-292. doi: 10.1093/phe/phy013. eCollection 2018 Nov.
4
Tuberculosis结核病
5
Efficiency and equity considerations in the preferences of health policy-makers in Israel.以色列卫生政策制定者偏好中的效率与公平考量。
Isr J Health Policy Res. 2017 Apr 1;6:18. doi: 10.1186/s13584-017-0142-7. eCollection 2017.
6
Is 'health equity' bad for our health? A qualitative empirical ethics study of public health policy-makers' perspectives.“健康公平”是否对我们的健康不利?一项关于公共卫生政策制定者观点的定性实证伦理研究。
Can J Public Health. 2018 Dec;109(5-6):633-642. doi: 10.17269/s41997-018-0128-4. Epub 2018 Nov 21.
7
Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.精准医疗,首次就诊:高度个性化和基于评估的青少年心理健康管理医疗模式。
Med J Aust. 2019 Nov;211 Suppl 9:S3-S46. doi: 10.5694/mja2.50383.
8
Risk management frameworks for human health and environmental risks.人类健康与环境风险的风险管理框架。
J Toxicol Environ Health B Crit Rev. 2003 Nov-Dec;6(6):569-720. doi: 10.1080/10937400390208608.
9
Economic evaluation and mental health: sparse past. fertile future?经济评估与心理健康:过往寥寥,未来可期?
J Ment Health Policy Econ. 1999 Dec 1;2(4):163-167. doi: 10.1002/(sici)1099-176x(199912)2:4<163::aid-mhp64>3.0.co;2-1.
10
Putting equity in health back onto the social policy agenda: experience from South Africa.将健康公平重新提上社会政策议程:来自南非的经验。
Soc Sci Med. 2002 Jun;54(11):1637-56. doi: 10.1016/s0277-9536(01)00332-x.

引用本文的文献

1
Disadvantage and the Experience of Treatment for Multidrug-Resistant Tuberculosis (MDR-TB).耐多药结核病(MDR-TB)的治疗劣势与经验
SSM Qual Res Health. 2022 Dec;2. doi: 10.1016/j.ssmqr.2022.100042. Epub 2022 Jan 28.
2
A cross-sectional study of COVID-19-related bullying in a sample of Lebanese adults: scale validation, correlates, and mediating effect of fear and anxiety.黎巴嫩成年人 COVID-19 相关欺凌现象的横断面研究:量表验证、相关性以及恐惧和焦虑的中介效应。
BMC Psychol. 2021 Sep 8;9(1):137. doi: 10.1186/s40359-021-00643-1.
3
Social stigma in the time of coronavirus disease 2019.

本文引用的文献

1
A scoping review of health-related stigma outcomes for high-burden diseases in low- and middle-income countries.高负担疾病在中低收入国家的健康相关污名后果的范围综述。
BMC Med. 2019 Feb 15;17(1):17. doi: 10.1186/s12916-019-1250-8.
2
Ethical Considerations for Global Health Decision-Making: Justice-Enhanced Cost-Effectiveness Analysis of New Technologies for .全球卫生决策的伦理考量:新技术的正义增强型成本效益分析
Public Health Ethics. 2018 Jul 18;11(3):275-292. doi: 10.1093/phe/phy013. eCollection 2018 Nov.
3
Would pan-tuberculosis treatment regimens be cost-effective?
2019 冠状病毒病时期的社会耻辱。
Eur Respir J. 2020 Aug 13;56(2). doi: 10.1183/13993003.02461-2020. Print 2020 Aug.
泛结核病治疗方案是否具有成本效益?
Lancet Respir Med. 2018 Jul;6(7):486-488. doi: 10.1016/S2213-2600(18)30197-8. Epub 2018 May 31.
4
The Use of MCDA in HTA: Great Potential, but More Effort Needed.多准则决策分析在卫生技术评估中的应用:潜力巨大,但仍需努力。
Value Health. 2018 Apr;21(4):394-397. doi: 10.1016/j.jval.2017.10.001. Epub 2017 Nov 22.
5
Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies.结核病:新药、治疗方案和宿主导向治疗的开发进展和进展。
Lancet Infect Dis. 2018 Jul;18(7):e183-e198. doi: 10.1016/S1473-3099(18)30110-5. Epub 2018 Mar 23.
6
Integrating social justice concerns into economic evaluation for healthcare and public health: A systematic review.将社会公正问题纳入医疗保健和公共卫生的经济评估中:系统评价。
Soc Sci Med. 2018 Feb;198:27-35. doi: 10.1016/j.socscimed.2017.12.012. Epub 2017 Dec 14.
7
Incorporating social justice and stigma in cost-effectiveness analysis: drug-resistant tuberculosis treatment.将社会公正和污名著入成本效益分析:耐多药结核病治疗。
Int J Tuberc Lung Dis. 2017 Nov 1;21(11):69-74. doi: 10.5588/ijtld.16.0839.
8
Incremental Cost Effectiveness of Bedaquiline for the Treatment of Rifampicin-Resistant Tuberculosis in South Africa: Model-Based Analysis.贝达喹啉治疗南非利福平耐药结核病的增量成本效果:基于模型的分析。
Appl Health Econ Health Policy. 2018 Feb;16(1):43-54. doi: 10.1007/s40258-017-0352-8.
9
Disability weights for the Global Burden of Disease 2013 study.全球疾病负担 2013 研究的失能权重。
Lancet Glob Health. 2015 Nov;3(11):e712-23. doi: 10.1016/S2214-109X(15)00069-8.
10
Investing in justice: ethics, evidence, and the eradication investment cases for lymphatic filariasis and onchocerciasis.投资于公平:伦理、证据与淋巴丝虫病和盘尾丝虫病的根除投资案例
Am J Public Health. 2015 Apr;105(4):629-36. doi: 10.2105/AJPH.2014.302454. Epub 2015 Feb 25.